Albemarle (ALB) — Stock Analysis 2026 [4.1]

Analysis as of 26 August 2026. Price deck (lithium carbonate, US$/t LCE): base US$15,000/t, with the full grid — bear US$10,000 / base US$15,000 / bull US$20,000 / strong bull US$25,000 / extreme bull US$30,000 — as the scenario set; spot ~US$18,300/t (Benchmark, battery-grade, CIF Asia) as a cross-check. Method: sum-of-the-parts on mid-cycle segment EBITDA (no group DCF). Rating: ★★★★ Solid quality / Fairly valued (wide band) → priced about right — the lithium recovery is largely in the price. Refreshed on each annual report and on material events. All figures in US dollars. For information only, prepared with AI assistance — see the disclaimer at the end.

Albemarle is the world’s largest lithium producer, and it owns the two best lithium assets on the planet — a half-share of Greenbushes and all of the Salar de Atacama. The thesis in one line: a genuinely tier-one lithium resource base plus a stable, cash-generative bromine business, coming out of the deepest lithium price crash in a decade with the balance sheet repaired — attached to a share price that has already tripled off its low. It is worth a look now because the cycle has turned: lithium carbonate has recovered from a ~US$10,000/t trough toward ~US$18,000/t, second-quarter 2026 EBITDA more than doubled year-over-year to US$858 million, and net debt is back below 0.5× EBITDA — but the equity, at ~US$132, is pricing much of that recovery in. To screen Albemarle against every lithium and battery-metals name on the same fields, go to Metal Pilot.

1. Snapshot & thesis

Figure 1. Albemarle in numbers, as of 26 August 2026

Figure data: Table 1, this analysis.

Table 1. Albemarle in numbers

Source: Albemarle Corporation Form 10-K 2025 (segments, production, reserves, dividends, net loss, cash flow); Q2 2026 results (Q2 EBITDA, net debt, guidance); share price and share count per stockanalysis.com , as of 26 Aug 2026. Lithium reserves are SK-1300 estimates; LCE converted at 0.1878 t Li metal per t LCE per the 10-K. Adjusted EBITDA is a non-GAAP measure defined in the 10-K.

Here for the verdict? The statcards above and the rating in Section 9 are the whole story. Want the evidence? Read Section 2 (the assets) through Section 7 (the valuation).

Thesis in brief. The bull case is asset quality and a turning cycle: Albemarle owns a 49% share of Greenbushes — the largest, highest-grade, lowest-cost hard-rock lithium mine in the world — plus 100% of the Salar de Atacama, one of two tier-one lithium brines, and it makes money in bromine when lithium is at its worst. It cut capital expenditure from US$2.2 billion (2023) to US$0.6 billion (2025), idled high-cost conversion, and deleveraged to ~0.5× EBITDA, so it enters the recovery lean. The bear case is that the recovery is largely priced: the shares have run from a ~US$71 low to ~US$132, the market already embeds roughly US$15,400/t lithium in perpetuity, mid-cycle free cash flow after growth capital is thin, and the company destroyed capital building capacity at the top of the last cycle — US$1.4 billion of write-offs in 2024 and US$0.4 billion more in 2025. What tips it is whether lithium sustains above ~US$16,000/t against a widely-forecast 2027 surplus. Section 9 has the full rating.

2. Assets & operations

Lithium is the most violently cyclical of the battery metals: the carbonate price ran from ~US$6,000/t in 2020 to ~US$80,000/t in late 2022 and back below US$10,000/t by 2024, before the recovery to ~US$18,000/t underway now. For the market backdrop behind that cycle — supply, demand, the cost curve and the 2027 surplus debate — see the Lithium — A Complete Market Guide . Albemarle’s entire strategy is built to survive the bottom of it and own the best assets at the top.

2.1 Portfolio overview & map

Albemarle runs three reportable segments — Energy Storage (lithium), Specialties (bromine and lithium specialties) and Ketjen (refining catalysts, being divested) — behind a mineral portfolio of nine properties across four countries, plus a global conversion network.

Table 2. Portfolio at 31 December 2025

Source: Albemarle 10-K 2025 , mineral reserves and production tables and the SK-1300 technical report summaries (Exhibits 96.1–96.6). Reserves are attributable proven-and-probable (Li) and proven (Br); Greenbushes and Wodgina are the company’s JV-share attributions. Output is FY2025 attributable production converted to LCE at 0.1878 t Li/t LCE (Kemerton, Chengdu conversion suspended). Conversion plants (La Negra, Kemerton, Meishan, Qinzhou, Xinyu) process the feedstock into battery-grade salts.

Concentration is the reverse of the usual worry — the assets are extraordinary, but two of them are joint ventures Albemarle does not operate. Greenbushes and the Salar de Atacama together are the core of the company, and both are tier-one; but Greenbushes is 49%-held and operated by Talison, and Wodgina is 50/50 with Mineral Resources, which operates it. So Albemarle’s two largest lithium sources are run by partners — a structural feature that shows up in the governance and risk sections. The map itself is skipped (see §10.1); the table and this paragraph carry the footprint.

2.2 Revenue split — by segment & by asset

Figure 2. FY2025 net sales by segment

Figure data: Albemarle 10-K 2025 , segment net sales. Energy Storage adjusted EBITDA was $697m, Specialties $276m, Ketjen $150m — so bromine and catalysts contribute ~39% of segment EBITDA on ~47% of sales, a bigger share of profit than sales in a weak-lithium year.

Figure 3. FY2025 attributable lithium production by asset

Figure data: Albemarle 10-K 2025 , production by property (lithium metal), converted to LCE at 0.1878 t Li/t LCE. Greenbushes and Wodgina figures are Albemarle’s 49% and 50% JV attributions.

The two figures read together are the whole shape of the company. On revenue, lithium is a bare majority; on the durable asset base, it is the story — Greenbushes and Atacama are two of the finest lithium assets in existence, and 45% of the lithium comes from a mine Albemarle owns less than half of. The bromine business (Specialties) is the ballast: in the worst lithium year in a decade it still earned US$276 million of EBITDA and grew it 21%, which is why Albemarle stayed cash-generative through the crash while lithium pure-plays bled.

2.3 Greenbushes

Greenbushes, in the south-west of Western Australia, is the best hard-rock lithium mine in the world — the largest by production and reserves and the highest-grade at scale, with 79.8 Mt of attributable proven-and-probable reserves at 1.9% Li₂O, roughly double the grade of a typical spodumene deposit. Albemarle holds its interest through a 49% stake in the Windfield joint venture (alongside Sichuan Tianqi Lithium), which owns the mine operated by Talison; the interest was assumed in 2015 through the Rockwood Holdings acquisition. It contributed about 101 kt LCE (19 kt Li metal) of attributable production in 2025 — the single largest source.

The economics are the point: Greenbushes sits at the bottom of the global lithium cost curve, so it makes money at prices that shut higher-cost spodumene in. The third chemical-grade plant (CGP3) is expected to reach commercial production during 2026, lifting concentrate capacity. The key asset-level risk is that Albemarle neither controls nor operates it — it is a minority partner in a mine run by Talison on behalf of a JV in which a Chinese lithium major is the co-owner, so expansion pace, offtake and capital calls are shared decisions.

2.4 Salar de Atacama & La Negra

The Salar de Atacama in northern Chile is the crown jewel Albemarle does control — a 100%-owned brine operation in one of the driest places on earth, with reserves of 308 kt of contained lithium at a very high 2,270 mg/L grade and a measured-and-indicated resource of 1,422 kt. Brine is concentrated through 18–24 month solar evaporation, which keeps operating cost among the lowest in the industry at a life-of-mine ~US$6,742/t LCE, then processed at La Negra. It produced about 75 kt LCE in 2025.

Two things constrain it, and both are structural. First, the resource sits under a Chilean regulatory and political framework — production and sales are governed by a CORFO lease with volume quotas, and Chile’s move toward a state-anchored national lithium strategy (through Codelco and SQM) is the backdrop against which any future expansion is negotiated. Second, water: an early-warning plan with defined brine and groundwater thresholds can trigger reduced extraction rates or halted pumping to protect the surrounding hydrology. The Salar Yield Improvement plant and direct-lithium-extraction studies aim to lift output within the authorised quota. The key asset-level risk is the Chilean quota-and-contract regime, which caps how much of this exceptional resource Albemarle can actually sell.

2.5 Wodgina, the US assets & the bromine franchise

Wodgina (Western Australia) is a large hard-rock spodumene mine held 50/50 in the MARBL joint venture with Mineral Resources, which operates it; Albemarle moved to 50% (from 60%) in the October 2023 MARBL restructuring, in which it also took full ownership of the Kemerton hydroxide plant. Wodgina holds 51.1 Mt of attributable P&P at 1.3% Li₂O and a 750 ktpa spodumene plant, and produced ~43 kt LCE in 2025. Silver Peak (Nevada) is the only operating lithium source in the United States — small (~5 kt LCE) but strategically and politically valuable. Kings Mountain (North Carolina), a 100%-owned development-stage hard-rock resource (63.9 Mt indicated at 1.4%, a planned ~420 kt/yr concentrator), is Albemarle’s option on a domestic US spodumene supply chain; Antofalla (Argentina) is an exploration-stage brine with 903 kt of M&I lithium.

The bromine franchise (within Specialties) is the ballast asset and deserves its own mention. Albemarle is the world’s number-two bromine producer, supplying bromine-based flame retardants and fire-safety solutions from Magnolia (Arkansas, 2,658 kt Br reserves, 69 kt output) and the 50%-owned JBC joint venture at Safi, Jordan (Arab Potash the partner, a Dead Sea concession running to 2058, ~125 kt/yr capacity, 57 kt attributable output). Bromine is a stable, oligopolistic specialty business that earned US$276 million of EBITDA in 2025 and is the reason the group’s profit does not go to zero when lithium does.

Ketjen (refining catalysts) is being wound out of the portfolio: on 25 October 2025 Albemarle agreed to divest the controlling interest in Ketjen’s Refining Solutions business to ChemCat (expected to close Q1 2026, Albemarle retaining a 49% Holdco stake and the PCS business), and it sold its 50% of the Eurecat JV to Axens in January 2026. Ketjen earned US$150 million of EBITDA in 2025.

2.6 Production, reserves & costs

Attributable lithium production was ~224 kt LCE (42 kt Li metal) in 2025, with Energy Storage sales volume up 9%; the segment’s sales fell 10% because unfavourable lithium pricing cut ~US$592 million from revenue. That gap — rising volume, falling revenue — is the lithium cycle in one line. Bromine production was 126 kt.

Reserves and cost position. Albemarle’s attributable proven-and-probable lithium reserves are roughly 1,399 kt of contained lithium (~7.4 Mt LCE), across Greenbushes (~705 kt Li), Wodgina (~309 kt), Atacama (308 kt) and Silver Peak (78 kt), with a much larger measured-and-indicated resource base behind it and two development options (Kings Mountain, Antofalla) on top. Its brine operations sit at ~US$6,700–6,800/t LCE life-of-mine operating cost and Greenbushes at the bottom of the hard-rock curve — so on the durable measure that matters through the cycle, Albemarle’s resource cost position is first-quartile. The weakness has been conversion, not extraction: the Kemerton hydroxide plant in Australia was high-cost and is now idled (Train 1 idled February 2026, Trains 2–4 stopped or in care and maintenance), a costly lesson in building conversion capacity into a price peak.

2.7 Peer positioning

Peer set: the four other major listed lithium producers — SQM (NYSE: SQM), Ganfeng Lithium (SZSE: 002460 / HK: 1772), Pilbara Minerals (ASX: PLS) and Mineral Resources (ASX: MIN). Basis: large lithium producers spanning brine and hard rock. SQM is the closest comparable — it co-produces from the Salar de Atacama alongside Albemarle and, like Albemarle, pairs lithium with a specialty-chemicals business (iodine and potassium). Arcadium is excluded (acquired by Rio Tinto in 2025 and no longer independent). Every scorecard reference and the §7 relative read use this set.

Table 3. Quality metrics against the peer set (indicative)

Source: company disclosures and industry estimates; figures are indicative and approximate — lithium producers report on differing bases (attributable vs 100%, LCE vs spodumene, calendar vs fiscal year), so this table is a scale-and-tier comparison, not a like-for-like table. Albemarle’s ~224 kt LCE is FY2025 attributable production per the 10-K ; peer figures are approximate 2024–25 output. None of the peers is in a pending acquisition.

Albemarle is the largest lithium producer in the set and the only one with a genuinely tier-one position in both hard rock (Greenbushes) and brine (Atacama) — a diversity SQM (brine-heavy), Pilbara (hard-rock pure-play) and the others lack. Where it lags is that its two biggest lithium sources are JV-operated, and its conversion cost position is weaker than its extraction cost position. To run these same fields across the whole battery-metals universe, use the Metal Pilot lithium screener.

3. Financials & balance sheet

Table 4. Five-year financial summary (US$ millions except per-share)

Source: FY2023–FY2025 net sales, adjusted EBITDA, net income, capex and dividends from the Albemarle 10-K 2025 and FY2023 10-K ; FY2021–FY2022 from the company’s historical filings. Net income is heavily distorted by non-cash items — 2024 carried ~US$1.2 billion of restructuring and asset write-offs, 2025 US$181 million of goodwill and US$246 million of long-lived-asset impairment tied to the Ketjen divestiture — so adjusted EBITDA is the sounder trend measure. FY2021–FY2022 capex and net-debt figures are approximate. Net debt fell further after year-end: total debt was US$1.9 billion at 30 June 2026, ~0.5× EBITDA.

The table is the lithium cycle drawn in one company. Net sales went from US$3.3 billion (2021) to US$9.6 billion (2023) and back to US$5.1 billion (2025); adjusted EBITDA from US$0.9 billion to US$3.6 billion and back to US$1.1 billion. The two loss years, 2024 and 2025, are impairment-driven rather than cash losses — operating cash flow was US$1.3 billion in 2025, more than 100% of adjusted EBITDA — but the write-offs are real economic events: they are the capitalised cost of building conversion capacity into the 2022 price peak.

Figure 4. Adjusted EBITDA by fiscal year, FY2021–FY2025

Figure data: Table 4, this analysis. Net sales (US$5.14bn in 2025), the net loss (−US$511m, impairment-driven) and capex (cut to US$590m) are read from Table 4 rather than overlaid.

Segment detail. The SOTP the valuation rests on starts here:

Table 5. Segment results, FY2025 (US$ millions)

Source: Albemarle 10-K 2025 , segment information. Adjusted EBITDA is before the ~US$427 million of 2025 goodwill and long-lived-asset impairments, which sit below the segment line.

Balance sheet and liquidity. This is the repaired part of the story. Net debt was US$1,576 million at 31 December 2025 and total debt fell to US$1.9 billion by 30 June 2026 — roughly 0.5× adjusted EBITDA — after Albemarle cut capital expenditure 73% from its 2023 peak, redeemed the W. R. Grace subsidiary preferred equity for US$307 million (June 2025), took a US$350 million customer prepayment (January 2025) for spodumene and lithium salts through 2029, and applied proceeds from the Ketjen divestitures. Cash was US$1.6 billion at year-end 2025. The maturity ladder is spread — senior notes in 2027, 2029, 2032, 2044 and 2052 — with the 2022 Credit Agreement (covenants amended October 2024) behind it. The balance sheet that looked stretched at the trough is comfortably investment-grade again, which is the single biggest change from a year ago.

Hedging. Albemarle runs no commodity price hedging — lithium exposure is managed through index-referenced, variable-priced customer contracts that align revenue with the market, which is why results move so directly with the lithium price. Treasury hedges foreign currency mostly through natural hedges plus forward contracts (an aggregate notional of US$2.4 billion at year-end 2025, a negligible net liability of US$2.6 million), and interest-rate exposure is minimal (a 100 bp move changes annual interest expense by ~US$0.2 million). The absence of a commodity hedge is a deliberate design choice, not an oversight — but it means the equity is a direct play on lithium.

Capital returns. Albemarle has raised its dividend for 31 consecutive years and maintained it through the crash — US$1.62 per share in 2025 (US$0.405 quarterly), a ~1.2% yield and about US$187 million a year. Holding a dividend aristocrat’s record through the worst lithium prices in a decade, while cutting capex and idling plants, is genuine capital discipline. The read on capital allocation is not the dividend, though — it is the write-offs. Applying the framework in the Financial Metrics for Commodity Investing guide: the income statement’s headline loss is non-cash (impairments); the balance sheet now survives the down-cycle (0.5× leverage, spread maturities); and the cash flow backs the profit (OCF above EBITDA). The one cross-statement flag is historical, not current — a company that built US$4 billion of conversion capacity at the price peak and then impaired much of it has a capital-allocation record the §9 scorecard marks down, even as the current balance sheet earns a good mark.

4. Management, strategy & corporate structure

4.1 Management & governance

J. Kent Masters has been Chairman, President and Chief Executive Officer since April 2020, having joined the board in 2015 through the Rockwood acquisition and served as lead independent director from 2018; earlier he was an operating partner at Advent International and CEO of the engineering firm Foster Wheeler. He inherited the company before the boom, presided over the acquisition-and-expansion push at the peak, and has run the retrenchment since — the cost-cutting, the plant idling and the portfolio pruning that repaired the balance sheet. The senior team is CFO Neal R. Sheorey, COO Mark R. Mummert, Chief Commercial Officer Eric W. Norris, Chief Business Transformation Officer Melissa H. Anderson, and General Counsel Ander C. Krupa, with Michael J. Simmons running the (shrinking) Ketjen business.

Board oversight runs through standing committees including Audit and Nominating and Governance. The governance flag is role concentration — Masters holds Chairman, President and CEO simultaneously, a combination most governance codes discourage — set against an experienced, credentialed executive bench and a decisive operating response to the downturn.

4.2 Strategy & capital allocation

The stated strategy is to optimise cost and operating structure to compete at every point of the lithium price cycle while preserving growth optionality for EV and energy-storage demand. In practice, 2024–2026 has been a retrenchment executed with unusual decisiveness: a shift to a fully integrated functional operating model, a 6–7% global workforce reduction, construction of Kemerton Trains 3 and 4 stopped, Train 2 and the Chengdu plant placed in care and maintenance, and Train 1 idled in February 2026 with production transferred elsewhere. Capital allocation was reprioritised toward cash generation, working-capital release and sharply lower capex, supplemented by portfolio moves (the Ketjen divestitures, the Grace redemption, the customer prepayment).

The growth pipeline is preserved rather than pursued: Greenbushes CGP3 (commercial 2026), the Salar Yield Improvement plant and direct-lithium-extraction studies to lift Atacama output within quota, and Kings Mountain as a potential domestic US spodumene source. For 2026 the company guides Energy Storage volume roughly flat with profitability geared to a lithium price rebound. The capital-allocation verdict is two-sided: the retrenchment has been exemplary, but it was made necessary by an expansion that was mistimed, and the scorecard weighs both.

4.3 Ownership & corporate structure

Albemarle’s structure is a lattice of joint ventures and recent portfolio transactions, most consequential first:

• Ketjen divestitures (2025–2026): on 25 October 2025 Albemarle agreed to sell the controlling interest in Ketjen’s Refining Solutions business to ChemCat AcquisitionCo, contributing the remainder to ChemCat Holdings for an initial 49% of common units (close expected Q1 2026, PCS business retained); separately it sold its 50% of the Eurecat JV to Axens in January 2026.
• W. R. Grace preferred redemption (June 2025): redeemed the preferred equity of a Grace subsidiary — received in the 2021 sale of the fine chemistry services business — for US$307.4 million.
• Customer prepayment (January 2025): received US$350 million for specified spodumene and lithium-salt deliveries through 2029.
• MARBL restructuring (October 2023): acquired the remaining 40% of the Kemerton hydroxide plant within an ~US$380 million payment, while Wodgina moved to 50/50 with Mineral Resources, which operates it.

The lithium feedstock is anchored by the Windfield joint venture (49%, alongside Sichuan Tianqi) that owns Greenbushes via Talison; bromine by the 50%-owned, consolidated Jordan Bromine Company with Arab Potash, whose Dead Sea concession runs to 2058. Wholly-owned subsidiaries include the conversion network. The capital structure carries senior notes maturing 2027–2052 and the 2022 Credit Agreement. There is no controlling or cornerstone shareholder; Albemarle is a widely-held S&P 500 constituent.

5. ESG & sustainability

Albemarle’s sustainability framework is anchored in quantified targets: reduce Scope 1 and 2 carbon intensity of the Specialties and Ketjen segments 35% by 2030 (2019 baseline), grow Energy Storage carbon-intensity-neutral, and cut freshwater-use intensity 25% by 2030 in high-water-risk areas such as Chile and Jordan. It published a 2024 Sustainability Report against these goals.

The material, named programme is water stewardship at the Salar de Atacama: an early-warning plan with defined brine and groundwater thresholds triggers escalating monitoring, reduced extraction or halted pumping to protect the surrounding hydrology, alongside process-technology investment (direct lithium extraction, brine re-injection) to shrink the water footprint while expanding within quota. Safety is a genuine strength — the OSHA occupational injury-and-illness rate for employees and nested contractors was 0.16 in 2025, well below industry norms.

Table 6. ESG snapshot

Source: Albemarle 10-K 2025 and the company’s 2024 Sustainability Report, “Values-Led, Purpose-Driven.”

Assessed even-handedly, the ESG profile is a real strength tempered by a real license risk. Albemarle’s products enable decarbonisation (EV and grid-storage batteries; refinery-catalyst additives that cut SO₂ and NOₓ), its safety record is excellent, and its targets are quantified and baselined. But its best-controlled asset sits in one of the most water-stressed basins on earth, under a regulator and a public that watch brine extraction closely — the water-stewardship plan is both a genuine program and an acknowledgment that the Salar’s social licence is not guaranteed.

6. Risks

Table 7. Risk register

Source: Albemarle 10-K 2025 risk factors; the capital-allocation and conversion-cost reads are this analysis’s assessment of §2.6 and §3.

Figure 5. Risk heat-map

Figure data: Table 7, this analysis.

The one risk that dominates all the others is the lithium price. Everything Albemarle does well — the tier-one assets, the bromine ballast, the repaired balance sheet — is levered to a single volatile number, and a widely-forecast 2027 supply surplus is the reason the recovery could stall. The §7 valuation prices exactly that through the lithium-carbonate scenario grid, and the range it produces is unusually wide because the leverage is unusually high.

7. Valuation

Valuation as of 26 August 2026, in US dollars. Horizon: spot fair value. Price US$132. Deck (lithium carbonate, US$/t LCE): base US$15,000, with the full grid as the scenario set — bear US$10,000 / base US$15,000 / bull US$20,000 / strong bull US$25,000 / extreme bull US$30,000; spot ~US$18,300 and Albemarle’s index-referenced realisations as cross-checks. Method: sum-of-the-parts on mid-cycle segment EBITDA — no group DCF.

Albemarle is a diversified major — three segments with different economics — so the archetype calls for a sum-of-the-parts as the primary method, cross-checked against a blended EV/EBITDA and a through-cycle FCF yield. No group DCF is built: the value is a set of segment cash-flow streams at very different multiples, and the lithium half swings by a factor of four across the price cycle, so a single discounted model would hide more than it reveals. The task is to value each piece at a mid-cycle multiple and then flex the whole thing across the lithium price. The headline conclusion: on a base deck of US$15,000/t lithium the blended fair value is US$127.20 per share, against a price of US$132 — an implied −3.6%, a Fairly valued read, but on a very wide band (the bear case is US$67, the extreme-bull case US$323).

7.1 Method selection

Table 8. Method selection and weights

Source: this analysis. The weights deviate from the diversified-major default (SOTP 55% / EV-EBITDA 25% / FCF-yield 20%): 5% is shifted from the FCF-yield method to EV/EBITDA because at cyclical extremes the FCF-yield read is the least reliable — at trough lithium, growth-and-sustaining capex nearly consumes EBITDA, so the method collapses toward zero and understates the resource option. SOTP is the intrinsic family (55%); EV/EBITDA and FCF-yield share the cash-flow family (45%, under the 50% collinear cap). Cross-checks carry 0%.

7.2 Sum-of-the-parts

Table 9. SOTP build-up at base lithium (US$15,000/t), US$ billions

Source: this analysis, on segment adjusted EBITDA from the 10-K scaled to a mid-cycle US$15,000/t deck (Energy Storage EBITDA of ~US$1.5 bn at base, up from US$697 m at 2025’s ~US$10–12k realised prices). The multiples are this analysis’s — 9.0× for the lithium business (a mid-cycle multiple on a tier-one, first-quartile resource base), 9.0× for the stable bromine franchise, and a fixed ~US$1.0 bn for the shrinking Ketjen business (its retained PCS unit, the 49% Holdco stake and the divestiture proceeds). Net debt is the 30 June 2026 figure (~0.5× EBITDA).

Figure 6. SOTP build-up

Figure data: Table 9, this analysis.

7.3 Blended EV/EBITDA and the sensitivity

The blended method takes consolidated adjusted EBITDA at each lithium deck and one justified group multiple (8.5×), bridged through net debt. Because lithium EBITDA is so price-levered, the sensitivity is essential — Figure 7 shows the equity value per share across the lithium price and the blended multiple:

Figure 7. Equity value per share — lithium price × blended EV/EBITDA multiple (US$)

Figure data: this analysis’ EV/EBITDA model. Columns: the lithium-carbonate grid, US$10,000–30,000/t LCE; base US$15,000 at an 8.5× multiple. A one-rung (US$5,000/t) lithium move shifts equity value by roughly ±US$57/share (±45% at the base) — the leverage that makes the valuation read on a wide band. Consolidated EBITDA is US$1.15/1.90/2.70/3.55/4.40 bn across the columns, consistent with Albemarle’s own 2026 scenario range of US$0.9–4.4 bn.

7.4 Cross-checks

The market-implied read. Solve for the flat lithium carbonate price at which the blend returns the current US$132: it is about US$15,400/t — just above the US$15,000 base and roughly at the blend of spot and the trailing average. The market is not pricing an aggressive recovery, nor a relapse to the trough; at US$132 it pays for lithium at about where it trades today. That is the cleanest statement of the read: the shares are worth about what they cost if lithium holds near current levels.

Dividend and consensus. The dividend yields ~1.2% and is a 31-year-aristocrat cross-check on financial resilience, not a valuation input. Analyst consensus on Albemarle is wide and momentum-driven — targets have chased the recovering price — so it is carried at 0% weight; the useful observation is that the sell-side, like this analysis, has the shares near fair value after the rally rather than deeply mispriced.

7.5 Scenario analysis

Each column of the lithium grid is a coherent world, and every weighted method is recomputed in it (multiples held constant, so only the lithium price moves the underlying EBITDA — cycle normalised on one side, V17). These are illustrative scenarios, not forecasts.

Table 10. Every weighted method, every scenario (US$/share)

Source: this analysis. SOTP and EV/EBITDA scale with segment/consolidated EBITDA bridged through net debt; the FCF-yield method capitalises normalised free cash flow (EBITDA less ~US$0.8–0.9 bn capex, ~US$0.13 bn interest and cash tax) at a 6% target yield — which is why it nearly vanishes in the bear world, where capex consumes the cash flow. The bear world is the §6 lithium-price/2027-surplus risk realised.

7.6 Fair value & conclusion

Table 11. Fair-value blend

Source: this analysis; weights per §7.1 (the diversified-major set, with the FCF-yield weight trimmed). All figures in USD; horizon: spot fair value. Base contribution = weight × base value/share: 0.55 × 133.5 + 0.30 × 128.4 + 0.15 × 101.7 = US$127.20. Cross-checks (market-implied lithium ~US$15,400/t, dividend yield, consensus) carried at 0% weight.

Implied total return = −3.6% price + 1.2% dividend yield = −2.4%.

Figure 8. Valuation range

Figure data: Table 11, this analysis.

Value read: Fairly valued (wide band). The base-case blend of US$127.20 sits 3.6% below the US$132 price — inside the ±10% fairly-valued band — and the market-implied lithium price of ~US$15,400/t is right around current levels, so the recovery is substantially in the price rather than ahead of it. The band is extraordinarily wide because lithium EBITDA swings by a factor of four across the deck: the bear world (US$10,000/t, near the marginal cost floor) prices the shares at US$67, a 49% fall, while the extreme-bull world (US$30,000/t) is US$323, a 145% rise. This is a genuinely bimodal equity. Against a flat read on the base case, the asset base is the reason to hold and the lithium price is the reason it is not cheap: a best-in-class resource company fairly priced for the recovery it is already delivering.

Assumptions box. Valuation date 26 Aug 2026; balance-sheet as-of 30 Jun 2026; horizon spot fair value. Reporting currency USD. Price deck: lithium-carbonate grid US$10,000–30,000/t LCE, base US$15,000 (representative trailing average snapped to the US$5,000 rung, leaning conservative below the ~US$18,300 spot); spot and Albemarle’s index-referenced realisations as cross-checks. No group discount rate — SOTP on mid-cycle segment EBITDA multiples (Energy Storage 9.0×, Specialties 9.0×, blended group 8.5×), so the discount is embedded in the multiples. Share count 118.0 m (no material dilution). Cycle normalised on the metric side — the lithium price moves consolidated EBITDA (Albemarle’s own 2026 scenario range US$0.9–4.4 bn spans ~US$9–30/kg), multiples held constant across scenarios; peer basis EV/EBITDA on consolidated adjusted EBITDA. Method weights SOTP 55% / blended EV/EBITDA 30% / FCF-yield 15% (the default set with the FCF-yield weight trimmed, cash-flow family 45%). SOTP provenance: built by this analysis on segment adjusted EBITDA × mid-cycle multiples, Ketjen at ~US$1.0 bn. Primary yardstick: SOTP enterprise value, cross-checked on blended EV/EBITDA and FCF yield.

8. Near-term catalysts (1–3 years)

Table 12. Near-term catalysts

Source: Albemarle 10-K 2025 and Q2 2026 results . Timing is company guidance, not a guarantee, and the lithium-price catalyst is a market outcome outside the company’s control.

Two of these are already delivering, and the rest are optionality. The cost savings and the CGP3 ramp are in train, and the Ketjen close is near-certain. But the catalyst that moves the equity is the one Albemarle does not control — the lithium price — and the widely-forecast 2027 surplus is the reason to treat the recovery as a scenario rather than a certainty.

9. Rating & verdict

Table 13. The Metal Pilot Company Scorecard — Albemarle

Source: this analysis; every score cites its home section. Scored as a diversified-major archetype (segment-weighted, with a diversification credit under Dimension 1 and the capital-allocation record read into Dimension 6), against the peer set declared in §2.7. Σ(weight × score) = 0.75 + 0.60 + 0.75 + 0.60 + 0.45 + 0.25 + 0.25 + 0.19 + 0.25 = 4.09/5 → ★★★★. Weighted by dominant dimensions (asset quality, cost, reserves/life, balance sheet, capital allocation) at 15% each and the remaining dimensions (growth, management, jurisdiction, ESG) at 6.25% each, rounded to the nearest half-star.

The scorecard is barbelled: two ★★★★★ asset scores against a ★★★☆☆ capital-allocation mark. That is the finding. Albemarle owns the best lithium assets in the world and one of the best bromine franchises, has a genuinely deep reserve base, and enters the recovery with a repaired balance sheet — but it built conversion capacity into the last price peak, impaired much of it, and earned deeply negative returns on capital in the down-cycle. The raw materials are exceptional; the through-cycle capital stewardship has not been.

The bull case is that the cycle has turned and Albemarle owns the assets that win it: lithium has recovered to ~US$18,000/t, Q2 2026 EBITDA rose 155%, the cost base is lean after the retrenchment, Greenbushes CGP3 adds low-cost volume in 2026, and the bromine business keeps growing. On the upper scenarios the equity is worth far more than US$132.

The bear case is that the recovery is largely priced and the leverage cuts both ways. At US$132 the market embeds ~US$15,400/t lithium in perpetuity; a 2027 surplus that drags lithium back toward US$10,000/t implies a bear-case value of US$67, a 49% fall. The dividend yield is only ~1.2%, so there is little carry while waiting, and the capital-allocation record argues for caution about the next expansion decision.

What tips it is the lithium price, which Albemarle does not control. The valuation is a coin-flip on the base case (−3.6%) with a bimodal spread, so the edge is not price but timing and conviction on lithium. For an investor who believes the recovery holds above ~US$16,000/t, the asset base is best-in-class and the entry is fair; for one who fears the 2027 surplus, the downside is severe. The rating is a strong Solid, held out of the top band by capital allocation and jurisdiction rather than by any weakness in the assets themselves.

To rank Albemarle against every lithium and battery-metals producer on these same nine dimensions — resources, cost, reserve life, leverage — screen the sector on Metal Pilot.

10. Sources, methodology & disclaimer

10.1 Sources, methodology & data vintage

Company filings. Albemarle Corporation Form 10-K for the year ended 31 December 2025 , filed with the SEC — the spine of this analysis, supplying segment results, mineral reserves and resources (SK-1300, with the Exhibit 96.1–96.6 technical report summaries), production by property, the JV structure, dividends, the net loss and cash flow, and risk factors. Financial and operating results, the Q2 2026 run-rate and 2026 guidance are from Albemarle’s Second Quarter 2026 results , with prior-year comparatives from the historical 10-K filings.

Market and financial data. Share price, share count and market data from stockanalysis.com , as of 26 August 2026. Lithium carbonate spot pricing (~US$18,300/t, battery-grade, CIF Asia) is per Benchmark Mineral Intelligence as of mid-August 2026.

Peer set. SQM, Ganfeng Lithium, Pilbara Minerals and Mineral Resources are named with a stated basis in §2.7; none has a Metal Pilot analysis yet, so the peer figures are indicative industry estimates rather than scorecard-derived, and are labelled as such in Table 3. For the market backdrop, the Lithium — A Complete Market Guide ; for the financial framework, the Financial Metrics for Commodity Investing guide.

Methodology, and where it is weakest. Five choices shape this analysis. First, the valuation is a sum-of-the-parts on mid-cycle segment EBITDA, not a DCF — a diversified company with a four-fold-cyclical lithium half is better valued by piece and multiple than by one discounted model, and the segment multiples (9.0× lithium, 9.0× bromine) are this analysis’s, drawn from where cyclical-resource and stable-specialty businesses trade mid-cycle. Second, the mid-cycle EBITDA figures are estimates — Energy Storage EBITDA at US$1.5 bn on a US$15,000/t deck is scaled from the 2025 actual (US$697 m at ~US$10–12k) and cross-checked against Albemarle’s own 2026 scenario range of US$0.9–4.4 bn; they are illustrative, not guidance. Third, net income is set aside in favour of adjusted EBITDA and cash flow, because the 2024–2025 losses are dominated by non-cash impairments tied to the peak-cycle overbuild and the Ketjen divestiture. Fourth, the FCF-yield method is deliberately light-weighted (15% vs the 20% default) because it collapses toward zero at the trough, where capex consumes cash flow — a real signal, but one that would overstate downside if fully weighted. Fifth, Ketjen is valued at a fixed ~US$1.0 bn through the divestiture rather than modelled as an ongoing segment, consistent with the announced transaction.

Omitted figure. One figure from the standard set is omitted: the asset map. A proportional-symbol map of nine properties across four countries is not drawn here, so Table 2 and the §2.1 concentration prose carry the footprint instead.

Units. Lithium production and reserves lead in LCE (lithium carbonate equivalent), converted from lithium metal at 0.1878 t Li/t LCE per the 10-K, with contained-lithium tonnes given alongside; bromine in kt. All figures are US dollars.

Data as of 26 August 2026. Albemarle reported second-quarter 2026 results on 6 August 2026; this analysis incorporates the resulting run-rate and balance-sheet figures but not a full quarterly review. Refreshed on each annual report and on material events. Provenance: Albemarle Corporation — 10-K Filing — 2025.

10.2 Disclaimer & disclosure

This analysis is for informational purposes only and is not investment advice; do your own research or consult a licensed advisor. It is a point-in-time snapshot as of 26 August 2026 — the share price, the lithium price, the multiples and the valuation read all move, and the reserve, production and net-asset-value figures are estimates as of the dates stated. Mineral reserves are SK-1300 estimates and do not represent market value; resources are less certain than reserves. The segment EBITDA figures used in the valuation are this analysis’s mid-cycle estimates, not company guidance. The nine scorecard scores and the two-axis verdict are an analytical read of quality and price, not a personal buy or sell instruction. This report was prepared with AI assistance; figures were sourced from the company’s filings, SEC data and market data and reviewed, but readers should verify before acting. The author holds no position in Albemarle Corporation or any company named in the peer set as of the date of writing.